Treatment of high risk testicular tumour with high dose chemotherapy with peripheral blood stem cells

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN85255912

Enrollment

Registered

2003-09-12

Start date

1994-05-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer: Testicular Cancer Testicular

Interventions

High dose chemotherapy with peripheral blood stem cells vs no high dose

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Patients with histological proven non-seminomatous germ cell tumours 2. High risk factors as defined by MRC prognostic group

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
1. Time to white cell and platelet recovery 2. Confirmation of response 3. Assessment of toxicity by standard World Health Organisation (WHO) grades	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026